Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 34 Breast Neoplasms 8 Obesity 5 Neoplasms 5 Prostatic Neoplasms 4 Insulin Resistance 4 Pancreatic Neoplasms 3 Infertility 3 Endometrial Neoplasms 3 Diabetes Mellitus 3 Triple Negative Breast Neoplasms 2 Neuroendocrine Tumors 2 Mouth Neoplasms 2 Metabolic Syndrome 2 Liver Neoplasms 2 Hyperandrogenism 2 Diabetes, Gestational 2 Diabetes Mellitus, Type 2 2 Depression 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Anovulation 2 Weight Loss 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1

Interventions

Cyclophosphamide 17 fludarabine 13 Dexamethasone 12 Cisplatin 11 Rituximab 10 Gemcitabine 9 Paclitaxel 7 Lenalidomide 7 Decitabine 7 Cytarabine 7 Bendamustine Hydrochloride 7 fludarabine phosphate 6 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6 Etoposide 6 Carboplatin 6 Bortezomib 6 Radiotherapy 5 Injections 5 Azacitidine 5 camrelizumab 4 apatinib 4 Valproic Acid 4 Thalidomide 4 Procarbazine 4 Oxaliplatin 4 Drug Therapy 4 Antilymphocyte Serum 4 tislelizumab 3 pomalidomide 3 liposomal doxorubicin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Recurrence × Metformin × Clear all

NCT03538704 2018-05-29

ECFerSp

Peking University People's Hospital

Phase NA Unknown

Recurrence, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡